Summary of Financial Indicators

Financial Indicators (TRY)2022/122023/12
Total Assets28,199,127,77177,327,803,422
Total Liabilities21,778,401,30661,902,221,116
Paid-in Capital1,161,523,3631,161,523,363
Shareholder’s Equity6,420,726,46515,425,582,306
2022/122023/12
Premium Production25,173,422,67559,518,179,027
Gross Claims Paid-6,915,516,192-23,196,280,842
Operational Expenses-1.868.501.653-5,209,066,468
Investment Income4,111,822,22514,721,994,034
Investment Expenses-3,583,819,045-14,215,014,686
Net Investment Income528,003,180506,979,348
Extraordinary Income Expenses235,207,249-758,325,108
Technical Profit502,449,048
7,905,204,699
Net Profit941,403,3586,155,335,809
Ratios Regarding Asset Quality & Liquidity2022/122023/12
 Cash Ratio82%87%
 Liquidity Ratio104%105%
 Current Ratio113%114%
 Receivables from Premium and Reinsurance / Total Assets16%15%
 Asset Profitability4%12%
 Equity Profitability18%56%
Operational Ratios2022/122023/12
 Retention Ratio51%57%
 Claims Paid / (Claims Paid + Outstanding Claims)39%48%
Profitability Ratios2022/122023/12
 Net Loss/Premium Ratio105%82%
 Net Commission Ratio12%14%
 Net Expense Ratio15%12%
 Net Compound Ratio132%108%